Thank you for the excellent, sobering and very real perspective on the sad state of management at ZEN/RVX. You summed up the situation perfectly.

As much as I want liquidity througha NASDAQ I agree that with the current board and management the IPO would be a disaster.

I don't know Don but my impression is that he is cost driven (i.e.underpowering trials, not funding futility analysis) rather than "big idea" driven. The fact that he has been with one biotech for 20 years and has no other biotech experience I believe makes him narrow in his perspective. The fact that he is not attracting and embracing the best biotech business and finance people in the world worthy of a biotech company developing breakthrough medical science suggests he is either insecure or lacks the perspective required to move these companies to a value where they should be right now.

It (the Peter Principle) is common but always so frustrating for the people watching from the outside with no power to help get the situation resolved. In Don's case I think we will just watch him flounder with undervalued deals until the companies hit a crisis point.

I still haven't ruled out the possibility that the Covid trial or a Zenith event could result in significant success, in which case Don will be perceived as a hero by some, but it sure is not a good way to run a company.

GLTA

Toinv